Siirry suoraan sisältöön
Radiation Oncology Advances
Tallenna

Radiation Oncology Advances

sidottu, 2007
englanti
from combining radiation with a molecular targeted agent – namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of the biology of the EGF Receptor and its signaling pathway in Chap.
Painos
2008 ed.
ISBN
9780387367439
Kieli
englanti
Paino
446 grammaa
Julkaisupäivä
15.11.2007
Sivumäärä
336